Clinical Trial Update: Stage IV Colorectal CA ALIMTA [Phase 1, Phase 2]

View source ↗

Summary

A Mayo Clinic-sponsored Phase 1/2 trial evaluated pemetrexed (ALIMTA) in locally advanced unresectable or Stage IV colorectal cancer; the study has been complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Alimta (pemetrexed)

Snippet

Sponsor: Mayo Clinic | Conditions: Locally Advanced Unresectable or Stage IV Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED